retatrutide and heart ESC 2024: improves lipid cardiovascular risk profile in Phase II trial Retatrutide and Cardiovascular Risk: Evaluating

The mice were housed in groups of nine animals during the study, under controlled environment (22 1 C) with a relative humidity (50 10%) and a normal 12 h light cycle (at 8:00 pm lights off)

There is no definitive evidence supporting probiotics, digestive enzymes, or most other supplements specifically for GLP-1 nausea, though individual patients may report subjective benefit

More serious adverse events were observed in a small proportion of participants

Timing and injection technique also matter

If that makes you hesitate, youre not alone

The increase in heart rate in retatrutide trials is the side effect that regulators and clinicians are watching closely